The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO‐CALLED INTESTINAL‐TYPE CARCINOMA: An Attempt at a Histo‐Clinical Classification
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ON THE ROLE OF HETEROTOPIAS OF THE INTESTINAL EPITHELIUM IN THE PATHOGENESIS OF GASTRIC CANCER
Järvi, O., & Laurén., P. (1951) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1951.tb00101.x · Cited by 202
Self-citationThe pathology of simple gastritis
Magnus, H. A. (1946) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700580313 · Cited by 50
JÄRVI, O. H., & Laurén, P. (1964) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/apm.1964.62.1.1 · Cited by 24
Self-citation
Cited by
Items 101–163 of 163
Epidemiology of upper gastrointestinal malignancies
CREW, K. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.04.021 · Cited by 323
Liu, X., Shao, L., Liu, X., Ji, F., Mei, Y., Cheng, Y., Liu, F., Yan, C., Li, L., & Ling, Z. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2018.12.034 · Cited by 322
Signaling pathways and therapeutic interventions in gastric cancer
Lei, Z.-N., Teng, Q.-X., Tian, Q., Chen, W., Xie, Y., Wu, K., Zeng, Q., Zeng, L., Pan, Y., Chen, Z.-S., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01190-w · Cited by 322
p53 expression and prognosis in gastric carcinoma
Martin, H. M., Filipe, M. I., Morris, R. W., Lane, D. P., & Silvestre, F. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500604 · Cited by 321
Review of Atrophic Gastritis and Intestinal Metaplasia as a Premalignant Lesion of Gastric Cancer
Park, Y. H., & Kim, N. (2015) · Journal of Cancer Prevention · doi:10.15430/jcp.2015.20.1.25 · Cited by 321
Ott, K., Fink, U., Becker, K., Stahl, A., Dittler, H.-J., Busch, R., Stein, H., Lordick, F., Link, T., Schwaiger, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.574 · Cited by 318
Piessen, G., Messager, M., Leteurtre, E., Jean-Pierre, T., & Mariette, C. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b21c7b · Cited by 316
Watari, J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i18.5461 · Cited by 316
Variation in Gene Expression Patterns in Human Gastric Cancers
Chen, X., Leung, S. Y., Yuen, S. T., Chu, K.-M., Ji, J., Li, R., Chan, A. S. Y., Law, S., Troyanskaya, O. G., Wong, J., et al. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-12-0833 · Cited by 316
Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge
Pernot, S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i40.11428 · Cited by 314
Molecular Classification of Gastric Cancer: A New Paradigm
Shah, M. A., Khanin, R., Tang, L., Janjigian, Y. Y., Klimstra, D. S., Gerdes, H., & Kelsen, D. P. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2203 · Cited by 311
Early gastric cancer in Europe
EVERETT, S. M., & AXON, A. T. R. (1997) · Gut · doi:10.1136/gut.41.2.142 · Cited by 309
Jenkins, B. J., Grail, D., Nheu, T., Najdovska, M., Wang, B., Waring, P., Inglese, M., McLoughlin, R. M., Jones, S. A., Topley, N., et al. (2005) · Nature Medicine · doi:10.1038/nm1282 · Cited by 308
Control of gut differentiation and intestinal-type gastric carcinogenesis
Yuasa, Y. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1141 · Cited by 307
Song, H., Ekheden, I. G., Zheng, Z., Ericsson, J., Nyrén, O., & Ye, W. (2015) · BMJ · doi:10.1136/bmj.h3867 · Cited by 307
Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer
Lee, H. E., Chae, S. W., Lee, Y. J., Kim, M. A., Lee, H. S., Lee, B. L., & Kim, W. H. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604738 · Cited by 302
Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry
Huang, Y.-K., Wang, M., Sun, Y., Di Costanzo, N., Mitchell, C., Achuthan, A., Hamilton, J. A., Busuttil, R. A., & Boussioutas, A. (2019) · Nature Communications · doi:10.1038/s41467-019-11788-4 · Cited by 301
Takahashi-Kanemitsu, A., Knight, C. T., & Hatakeyama, M. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0339-5 · Cited by 299
Nakamura, Y., Kawazoe, A., Lordick, F., Janjigian, Y. Y., & Shitara, K. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00492-2 · Cited by 298
for the JPHC Study Group, Tsugane, S., Sasazuki, S., Kobayashi, M., & Sasaki, S. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601511 · Cited by 297
Muro, K., Lordick, F., Tsushima, T., Pentheroudakis, G., Baba, E., Lu, Z., Cho, B. C., Nor, I. M., Ng, M., Chen, L. T., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdy498 · Cited by 289
A proteomic landscape of diffuse-type gastric cancer
Ge, S., Xia, X., Ding, C., Zhen, B., Zhou, Q., Feng, J., Yuan, J., Chen, R., Li, Y., Ge, Z., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03121-2 · Cited by 288
Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach
Kim, T.-H., Kim, I.-H., Kang, S. J., Choi, M., Kim, B.-H., Eom, B. W., Kim, B. J., Min, B.-H., Choi, C. I., Shin, C. M., et al. (2023) · Journal of Gastric Cancer · doi:10.5230/jgc.2023.23.e11 · Cited by 288
PD-L1 is an independent prognostic predictor in gastric cancer of Western patients
Böger, C., Behrens, H.-M., Mathiak, M., Krüger, S., Kalthoff, H., & Röcken, C. (2016) · Oncotarget · doi:10.18632/oncotarget.8169 · Cited by 287
Update on Epstein-Barr virus and gastric cancer (Review)
SHINOZAKI-USHIKU, A., KUNITA, A., & FUKAYAMA, M. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2856 · Cited by 286
Guilford, P. J., Hopkins, J. B. W., Grady, W. M., Markowitz, S. D., Willis, J., Lynch, H., Rajput, A., Wiesner, G. L., Lindor, N. M., Burgart, L. J., et al. (1999) · Human Mutation · doi:10.1002/(sici)1098-1004(1999)14:3<249::aid-humu8>3.0.co;2-9 · Cited by 283
Targeted Therapies in Advanced Gastric Cancer
Patel, T. H., & Cecchini, M. (2020) · Current Treatment Options in Oncology · doi:10.1007/s11864-020-00774-4 · Cited by 282
Ando, T., Yoshida, T., Enomoto, S., Asada, K., Tatematsu, M., Ichinose, M., Sugiyama, T., & Ushijima, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24219 · Cited by 279
Is Barrett's Metaplasia the Source of Adenocarcinomas of the Cardia?
Clark, G. W. B. (1994) · Archives of Surgery · doi:10.1001/archsurg.1994.01420300051007 · Cited by 277
Gastric cancer screening using the serum pepsinogen test method
Miki, K. (2006) · Gastric Cancer · doi:10.1007/s10120-006-0397-0 · Cited by 275
Helicobacter pylori infection: Independent risk indicator of gastric adenocarcinoma
Hansson, L.-E., Engstrand, L., Nyrén, O., Evans, D. J., Lindgren, A., Bergström, R., Andersson, B., Athlin, L., Bendtsen, O., & Tracz, P. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90954-b · Cited by 272
The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites
Anderson, W. F., Rabkin, C. S., Turner, N., Fraumeni, J. F., Rosenberg, P. S., & Camargo, M. C. (2018) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx262 · Cited by 270
Li, J., Woods, S. L., Healey, S., Beesley, J., Chen, X., Lee, J. S., Sivakumaran, H., Wayte, N., Nones, K., Waterfall, J. J., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.03.001 · Cited by 270
FGFR2 -Amplified Gastric Cancer Cell Lines Require FGFR2 and Erbb3 Signaling for Growth and Survival
Kunii, K., Davis, L., Gorenstein, J., Hatch, H., Yashiro, M., Di Bacco, A., Elbi, C., & Lutterbach, B. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5229 · Cited by 269
Gene Expression Profile of Gastric Carcinoma
Oue, N., Hamai, Y., Mitani, Y., Matsumura, S., Oshimo, Y., Aung, P. P., Kuraoka, K., Nakayama, H., & Yasui, W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3514 · Cited by 265
HATAKEYAMA, M. (2017) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.93.013 · Cited by 261
Rugge, M., Farinati, F., Baffa, R., Sonego, F., Di Mario, F., Leandro, G., & Valiante, F. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90529-0 · Cited by 263
Shikata, K., Kiyohara, Y., Kubo, M., Yonemoto, K., Ninomiya, T., Shirota, T., Tanizaki, Y., Doi, Y., Tanaka, K., Oishi, Y., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21822 · Cited by 259
Findlay, M., Cunningham, D., Norman, A., Mansi, J., Nicolson, M., Hickish, T., Nicolson, V., Nash, A., Sacks, N., Ford, H., et al. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058932 · Cited by 257
Helicobacter pylori infection and chronic gastritis in gastric cancer.
Sipponen, P., Kosunen, T. U., Valle, J., Riihelä, M., & Seppälä, K. (1992) · Journal of Clinical Pathology · doi:10.1136/jcp.45.4.319 · Cited by 253
Cellular and molecular aspects of gastric cancer
Smith, M. G. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i19.2979 · Cited by 252
TP53 and gastric carcinoma: A review
Fenoglio-Preiser, C. M., Wang, J., Stemmermann, G. N., & Noffsinger, A. (2003) · Human Mutation · doi:10.1002/humu.10180 · Cited by 252
MYC-Dependent Regulation and Prognostic Role of CIP2A in Gastric Cancer
Khanna, A., Böckelman, C., Hemmes, A., Junttila, M. R., Wiksten, J.-P., Lundin, M., Junnila, S., Murphy, D. J., Evan, G. I., Haglund, C., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp103 · Cited by 185
Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer
Jiang, Y., Li, T., Liang, X., Hu, Y., Huang, L., Liao, Z., Zhao, L., Han, Z., Zhu, S., Wang, M., et al. (2017) · JAMA Surgery · doi:10.1001/jamasurg.2017.1087 · Cited by 152
Dietary factors and the risk of gastric cancer in Mexico city
Ward, M. H., & Lopez-Carrillo, L. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009736 · Cited by 136
AGA technical review on gastric intestinal metaplasia-epidemiology and risk factors
Altayar, O., Davitkov, P., Shah, S. C., Gawron, A. J., Morgan, D. R., Turner, K., & Mustafa, R. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.002 · Cited by 135
Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions
Song, H., Zhu, J., & Lu, D. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010623.pub2 · Cited by 132
“The Lauren’s classification divides gastric cancer into two major histologic types: intestinal or diffuse (Lauren 1965).”
BackgroundRelationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk
Masuyama, H., Yoshitake, N., Sasai, T., Nakamura, T., Masuyama, A., Zuiki, T., Kurashina, K., Mieda, M., Sunada, K., Yamamoto, H., et al. (2015) · Digestion · doi:10.1159/000368807 · Cited by 101
Chen, J., Liu, K., Luo, Y., Kang, M., Wang, J., Chen, G., Qi, J., Wu, W., Wang, B., Han, Y., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.03.008 · Cited by 84
Gastric Cancer Genomics: Advances and Future Directions
Katona, B. W., & Rustgi, A. K. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.01.003 · Cited by 78
Naito, Y., Sakamoto, N., Oue, N., Yashiro, M., Sentani, K., Yanagihara, K., Hirakawa, K., & Yasui, W. (2014) · Cancer Science · doi:10.1111/cas.12329 · Cited by 73
Benchmarking foundation models as feature extractors for weakly supervised computational pathology
Neidlinger, P., El Nahhas, O. S. M., Muti, H. S., Lenz, T., Hoffmeister, M., Brenner, H., van Treeck, M., Langer, R., Dislich, B., Behrens, H. M., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01516-3 · Cited by 80
Toyoshima, O., Yamaji, Y., Yoshida, S., Matsumoto, S., Yamashita, H., Kanazawa, T., & Hata, K. (2017) · Surgical Endoscopy · doi:10.1007/s00464-016-5211-4 · Cited by 59
Nam, J. H., Choi, I. J., Cho, S., Kim, C. G., Jun, J. K., Choi, K. S., Nam, B., Lee, J. H., Ryu, K. W., & Kim, Y. (2012) · Cancer · doi:10.1002/cncr.27495 · Cited by 58
Gong, E. J., Ahn, J. Y., Jung, H., Lim, H., Choi, K., Lee, J. H., Kim, D. H., Choi, K. D., Song, H. J., Lee, G. H., et al. (2014) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12387 · Cited by 51
Shi, W., Wang, Y., Xu, C., Li, Y., Ge, S., Bai, B., Zhang, K., Wang, Y., Zheng, N., Wang, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-35797-6 · Cited by 50
The Enterochromaffin-like [ECL] Cell—Central in Gastric Physiology and Pathology
Waldum, H. L., Sørdal, Ø. F., & Mjønes, P. G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102444 · Cited by 45
Silva, R., Gullo, I., & Carneiro, F. (2016) · Porto Biomedical Journal · doi:10.1016/j.pbj.2016.03.004 · Cited by 35
Shen, P.-W., Chou, Y.-M., Li, C.-L., Liao, E.-C., Huang, H.-S., Yin, C.-H., Chen, C.-L., & Yu, S.-J. (2021) · Oncology Letters · doi:10.3892/ol.2021.13029 · Cited by 23
Nakai, K., Lin, H., Yamano, S., Tanaka, S., Kitamoto, S., Saitoh, H., Sakuma, K., Kurauchi, J., Akter, E., Konno, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42774-6 · Cited by 14
Santos, E. C., Binato, R., Fernandes, P. V., Ferreira, M. A., & Abdelhay, E. (2022) · Cancer Biomarkers · doi:10.3233/cbm-203225 · Cited by 9
Brito, D. M. S., Lima, O. G., Mesquita, F. P., da Silva, E. L., de Moraes, M. E. A., Burbano, R. M. R., Montenegro, R. C., & Souza, P. F. N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092303 · Cited by 6
dos Santos, E. C., Rohan, P., Binato, R., & Abdelhay, E. (2023) · Cancers · doi:10.3390/cancers15225374 · Cited by 3
Metadata
- Authors
- LAURÉN, P.
- Venue
- Acta Pathologica Microbiologica Scandinavica
- Publisher
- Wiley
- Published
- 1965-09
- Volume
- 64
- Issue
- 1
- Pages
- 31-49
- ISSN
- 0365-5555 (ISSN-L)
- OpenAlex
- W2338576041
- Cited by
- 6,133
- References
- 3
- FWCI
- 5.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.